Leonard Resignation Leaves AAM Looking For New Leadership

Gaugh Steps In As Interim CEO Of US Generics And Biosimilars Association

Dan Leonard has announced his resignation as president and CEO of the US Association for Accessible Medicines. He will be replaced on an interim basis by the group’s vice president for sciences and regulatory affairs, David Gaugh.

Replacement of leader, CEO, wooden figures
As interim CEO, David Gaugh has replaced Dan Leonard • Source: Shutterstock

The US Association for Accessible Medicines is now looking for a new permanent leader, after the generics and biosimilars industry association announced that its current chief Dan Leonard would be stepping down from the position with immediate effect.

In a statement published by the AAM, Leonard said “today, I am announcing my resignation from the role of president and CEO of the AAM

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Generics Bulletin